Last week indices of Indian capital market consolidated with stability and strength getting positive cues from global markets, lowering inflation, progress of monsoon etc. Sensex ended at 17783.21 & Nifty at 5386.70.
Going forward, as said earlier, Indian markets will behave and move as per the sentiments of the FIIs, who are constantly buying and investing following stock specific approach neglecting the rising crude prices and discouraging macroeconomic domestic factors like inflation, interest rate, monsoon and political chaos. Markets will keep rising along with stocks till FIIs like the valuations........Buying on fundamentals is suggested.
Technically no trade zone for the Nifty is 5340 and 5450.
Buy Nifty Calls of 5400 & 5500 if Nifty rises above 5450, keeping 5340 as Stop-Loss for the target of 5520-5570-5610.
Buy Nifty Puts of 5400 & 5300 if Nifty breaks below 5340, keeping 5450 as Stop-Loss for the target of 5290-5250-5180.
Following Stocks should be bought in Delivery only(45-60 Days):
1. Shasun Pharma for the Target of 180-200++
2. Wochardt Pharma for the target of 1500-1600+++
3. Orrisa Mine for the target of 60000-68000+++
Safe Harbor Statement:
Some forward looking statements on projections, estimates, expectations & outlook are included to enable a better comprehension of the Company prospects. Actual results may, however, differ materially from those stated on account of factors such as changes in government regulations, tax regimes, economic developments within India and the countries within which the Company conducts its business, exchange rate and interest rate movements, impact of competing products and their pricing, product demand and supply constraints.Nothing in this article is, or should be construed as, investment advice.
Disclaimer:
This is neither an offer nor a solicitation to purchase or sell securities. The information and views contained on this blog are believed to be reliable, but no responsibility (or liability) is accepted for errors of fact or opinion. Writers and contributors may be trading in, or have positions in the securities mentioned in their articles. Neither I (Vikas Srivastava) nor any of the contributors accepts any liability arising out of use of the above information/article. Reproduction in whole or in part without written permission is prohibited.
Going forward, as said earlier, Indian markets will behave and move as per the sentiments of the FIIs, who are constantly buying and investing following stock specific approach neglecting the rising crude prices and discouraging macroeconomic domestic factors like inflation, interest rate, monsoon and political chaos. Markets will keep rising along with stocks till FIIs like the valuations........Buying on fundamentals is suggested.
Technically no trade zone for the Nifty is 5340 and 5450.
Buy Nifty Calls of 5400 & 5500 if Nifty rises above 5450, keeping 5340 as Stop-Loss for the target of 5520-5570-5610.
Buy Nifty Puts of 5400 & 5300 if Nifty breaks below 5340, keeping 5450 as Stop-Loss for the target of 5290-5250-5180.
Following Stocks should be bought in Delivery only(45-60 Days):
1. Shasun Pharma for the Target of 180-200++
2. Wochardt Pharma for the target of 1500-1600+++
3. Orrisa Mine for the target of 60000-68000+++
Safe Harbor Statement:
Some forward looking statements on projections, estimates, expectations & outlook are included to enable a better comprehension of the Company prospects. Actual results may, however, differ materially from those stated on account of factors such as changes in government regulations, tax regimes, economic developments within India and the countries within which the Company conducts its business, exchange rate and interest rate movements, impact of competing products and their pricing, product demand and supply constraints.Nothing in this article is, or should be construed as, investment advice.
Disclaimer:
This is neither an offer nor a solicitation to purchase or sell securities. The information and views contained on this blog are believed to be reliable, but no responsibility (or liability) is accepted for errors of fact or opinion. Writers and contributors may be trading in, or have positions in the securities mentioned in their articles. Neither I (Vikas Srivastava) nor any of the contributors accepts any liability arising out of use of the above information/article. Reproduction in whole or in part without written permission is prohibited.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.